Weight loss drugs Wegovy and Zepbound strain budgets amid skyrocketing copays
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.
Medicare May Soon Cover Ozempic, Wegovy Under New Biden Proposal
If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump administration.
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce risks with obesity.
Weight loss drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal
Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning.
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Should Medicare, Medicaid Cover Anti-Obesity Drugs? Doctors Speak Out
Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
Biden's plan to cover anti-obesity drugs could cost $140 billion
President Joe Biden's plan to authorize Medicare and Medicaid cover anti-obesity medications starting in 2026 would $140 billion over the next decade.
Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.
Biden proposes huge expansion of weight loss drug access
Outgoing US President Joe Biden proposed Tuesday to give millions more Americans access to weight loss drugs -- but Donald Trump's incoming health chief looked set to shoot down the
Futurism on MSN19h
Woman Annoyed When She Gets on Wegovy and It Does Nothing
For some, the issue with GLP-1 drugs like Ozempic and Mounjaro isn't getting access to these game-changing medications, but ...
The Economist2d
Wegovy hits the People’s Republic, at last
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...
Exclusive: Thousands turn to Wegovy copies each month as FDA considers shortage status
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
Newsday4d
Wegovy, Mounjaro: Suffolk County issues new guidelines for access to costly weight-loss drugs
The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...
The Best Foods to Eat When Taking Wegovy for Weight Loss
Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...
Medicare Could Pay for Wegovy. Don’t Count On It.
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
Why some people don’t lose weight with Wegovy
Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.
Pharmaceutical Technology2d
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial ...